Erratum: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: Feasibility, practice effects, test-retest reliability, and construct validity (Journal of Neurodevelopmental Disorders (2020) 12 (10) DOI: 10.1186/s11689-020-09313-6)

Leonard Abbeduto, Elizabeth Berry-Kravis, Audra Sterling, Stephanie Sherman, Jamie O. Edgin, Andrea McDuffie, Anne Hoffmann, Debra Hamilton, Michael Nelson, Jeannie Aschkenasy, Angela John Thurman

Research output: Contribution to journalComment/debate

Abstract

In the original publication of this article [1], the author name Leonard Abbeduto was misspelled as Leonardkk Abbeduto. The original article has been corrected.

Original languageEnglish (US)
Article number11
JournalJournal of Neurodevelopmental Disorders
Volume12
Issue number1
DOIs
StatePublished - Apr 2 2020

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Cognitive Neuroscience

Fingerprint Dive into the research topics of 'Erratum: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: Feasibility, practice effects, test-retest reliability, and construct validity (Journal of Neurodevelopmental Disorders (2020) 12 (10) DOI: 10.1186/s11689-020-09313-6)'. Together they form a unique fingerprint.

  • Cite this